题名

代謝健康／不健康之肥胖／過重與心血管疾病風險間的關係：台灣具代表性的世代研究

并列篇名

Association between metabolically healthy/ unhealthy obesity/ overweight and the risk of cardiovascular disease: a representative cohort study in Taiwan

DOI

10.6288/TJPH.202010_39(5).109111

作者

葉姿麟(Tzu-Lin Yeh)；簡國龍(Kuo-Liong Chien)

关键词

代謝健康肥胖 ； 代謝症候群 ； 心血管疾病 ； 三高主題資料庫 ； 社區前瞻性世代研究 ； metabolically healthy obesity ； metabolic syndrome ； cardiovascular disease ； Taiwanese Survey on Hypertension, Hyperglycemia, and Hyperlipidemia databases ； community-based prospective cohort study

期刊名称

台灣公共衛生雜誌

卷期/出版年月

39卷5期（2020 / 10 / 28）

页次

553 - 564

内容语文

繁體中文
中文摘要

目標：探討台灣代謝健康肥胖者（Metabolically healthy obesity, MHO）和心血管疾病（Cardiovascular disease, CVD）間的關係。方法：受試者來自於三高主題資料庫。本研究將身體質量指數（body mass index, BMI）區分為：體重過輕（BMI ＜ 18.5 kg/m^2）、正常體重（BMI18.5至23.9 kg/m^2）和肥胖／過重（BMI ≥24 kg/m^2）。無糖尿病、高血壓、高血脂症且符合以下定義為代謝健康：（1）空腹三酸甘油酯 ＜150 mg/dL；（2）男性高密度脂蛋白膽固醇 ≥40 mg/dL或女性高密度脂蛋白膽固醇 ≥50 mg/dL；（3）空腹血糖 ＜100 mg/dL；（4）收縮壓 ＜130且舒張壓 ＜85mmHg。研究終點是以全民健康保險資料確認之發生CVD事件或死亡。使用Cox迴歸模型估計風險比（hazard ratio, HRs）和95%信賴區間（confidence interval, CI）。結果：5,719名受試者年齡平均值（標準差）為44.0（15.5）歲，50.2%為女性，其中1,479名為參考組（代謝健康正常體重者），493名MHO者平均年齡43.3歲，女性比例47.1%。在追蹤中位數（四分位差）13.7（13.6-13.8）年間，共發生了449個CVD事件或死亡，其中MHO組發生了25個CVD事件或死亡。MHO組經多變項調整後之HR為1.75，意即相較於參考組顯著增加了75%的CVD風險，95%CI為1.02－2.99。結論：無論目前代謝健康與否，鼓勵所有肥胖者應積極維持正常體重，以減少將來之CVD風險。
英文摘要

Objectives: To investigate the relationship between individuals with metabolically healthy obesity (MHO) and the cardiovascular disease (CVD) risk in Taiwan. Methods: Participants from the Taiwanese Survey on Hypertension, Hyperglycemia, and Hyperlipidemia databases were recruited, and classified into three body mass index (BMI) categories: underweight (BMI ＜ 18.5 kg/m^2), normal weight (BMI 18.5 to 23.9 kg/m^2), and overweight/obesity (BMI ≥24 kg/m^2). Participants without diabetes, hypertension, hyperlipidemia and had healthy metabolic profiles (1) fasting triglyceride ＜150 mg/dL; (2) high-density lipoprotein cholesterol ≥40 mg/dL in men or ≥50 mg/dL in women; (3) fasting glucose ＜100 mg/dL; (4) systolic blood pressure ＜130 and diastolic blood pressure ＜85 mmHg were defined as metabolically health. Our endpoints were CVD events or death, ascertained by the National Health Insurance Research Database. Multivariable adjusted hazard ratios (HRs) and 95% confidence intervals (CI) by Cox regression analysis were performed. Results: A total of 5,719 participants with mean (standard deviation) age 44.0 (15.5) years old, 50.2% women was recruited. Among the total participants, 1,479 individuals were metabolically healthy normal weight (the reference group), 493 participants were the MHO group with the mean age 43.3 years old and women percentage 47.1%. During a median (interquartile range) follow-up time of 13.7 (13.6-13.8) years, 449 ascertained CVD events or deaths developed, 25 CVD events or deaths developed in the MHO group. Compared with the reference group, MHO had a significant higher CVD risk, adjusted HR with 95% CI was 1.75 (1.02-2.99). Conclusions: Aggressive body weight control, even in current metabolically healthy status, is mandatory for CVD control.
主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. Al-khalidi, B,Kimball, SM,Kuk, JL,Ardern, CI(2019).Metabolically healthy obesity, vitamin D, and all-cause and cardiometabolic mortality risk in NHANES III.Clin Nutr,38,820-828.
  2. Arnlöv, J,Ingelsson, E,Sundström, J,Lind, L(2010).Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.Circulation,121,230-236.
  3. Aung, K,Lorenzo, C,Hinojosa, MA,Haffner, SM(2014).Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals.J Clin Endocrinol Metab,99,462-468.
  4. Bo, S,Musso, G,Gambino, R(2012).Prognostic implications for insulin-sensitive and insulinresistant normal-weight and obese individuals from a population-based cohort.Am J Clin Nutr,96,962-969.
  5. Brandão, I,Martins, MJ,Monteiro, R(2020).Metabolically healthy obesity-heterogeneity in definitions and unconventional factors.Metabolites,10,48.
  6. Clegg, D,Hevener, AL,Moreau, KL(2017).Sex hormones and cardiometabolic health: role of estrogen and estrogen receptors.Endocrinology,158,1095-1105.
  7. De Lorenzo, A,da Cruz Lamas, C,Lessa, R,Moreira, ASB(2018)."Metabolically Healthy" obesity: fact or threat?.Curr Diabetes Rev,14,405-410.
  8. Dhana, K,Koolhaas, CM,Van Rossum, EFC(2016).Metabolically healthy obesity and the risk of cardiovascular disease in the elderly population.PLoS One,11,e0154273.
  9. Eckel, N,Li, Y,Kuxhaus, O,Stefan, N,Hu, FB,Schulze, MB(2018).Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90,257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study.Lancet Diabetes Endocrinol,6,714-724.
  10. Eckel, N,Meidtner, K,Kalle-Uhlmann, T,Stefan, N,Schulze, MB(2016).Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis.Eur J Prev Cardiol,23,956-966.
  11. Flint, AJ,Hu, FB,Glynn, RJ(2010).Excess weight and the risk of incident coronary heart disease among men and women.Obesity,18,377-383.
  12. Hansen, L,Netterstrøm, MK,Johansen, NB(2017).Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the inter99 study.J Clin Endocrinol Metab,102,1934-1942.
  13. Hinnouho, GM,Czernichow, S,Dugravot, A(2015).Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study.Eur Heart J.,36,551-559.
  14. Ho Chan, WS(2010).Taiwan’s healthcare report 2010.EPMA J,1,563-585.
  15. Hosmer, DW,Lemeshow, S.(1999).Applied Survival Analysis: Regression Modeling of Time to Event Data.New York, NY:John Wiley & Sons, Inc.
  16. Hosseinpanah, F,Barzin, M,Sheikholeslami, F,Azizi, F(2011).Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS).Am J Cardiol,107,412-416.
  17. Hsueh, YW,Yeh, TL,Lin, CY(2020).Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis.PeerJ,8,e8815.
  18. Hwang, LC,Bai, CH,Sun, CA,Chen, CJ(2012).Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan.Asia Pac J Clin Nutr,21,227-233.
  19. Jung, CH,Lee, WJ,Song, KH(2017).Metabolically healthy obesity: a friend or foe?.Korean J Intern Med,32,611-621.
  20. Kabootari, M,Akbarpour, S,Azizi, F,Hadaegh, F(2019).Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study.Nutr Metab,16,16.
  21. Katzmarzyk, PT,Church, TS,Janssen, I,Ross, R,Blair, SN(2005).Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness.Diabetes Care,28,391-397.
  22. Kip, KE,Marroquin, OC,Kelley, DE(2004).Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study.Circulation,109,706-713.
  23. Kuk, JL,Ardern, CI(2009).Are metabolically normal but obese individuals at lower risk for all-cause mortality?.Diabetes Care,32,2297-2299.
  24. Lassale, C,Tzoulaki, I,Moons, KGM(2018).Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.Eur Heart J,39,397-406.
  25. Lee, SH,Jeong, MH,Kim, JH(2018).Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment elevation myocardial infarction in men undergoing primary percutaneous coronary intervention.J Cardiol,72,328-334.
  26. Li, L,Chen, K,Wang, A(2019).Cardiovascular disease outcomes in metabolically healthy obesity in communities of Beijing cohort study.Int J Clin Pract,73,e13279.
  27. Meigs, JB,Wilson, PWF,Fox, CS(2006).Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.J Clin Endocrinol Metab,91,2906-2912.
  28. Mørkedal, B,Vatten, LJ,Romundstad, PR,Laugsand, LE,Janszky, I(2014).Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag Health Study), Norway.J Am Coll Cardiol,63,1071-1078.
  29. Nilsson, PM,Korduner, J, ,Magnusson, M(2020).Metabolically Healthy Obesity (MHO) -- new research directions for personalised medicine in cardiovascular prevention.Curr Hypertens Rep,22,18.
  30. O’Rourke, K,VanderZanden, A,Shepard, D,Leach-Kemon, K,Institute for Health Metrics and Evaluation(2015).Cardiovascular disease worldwide, 1990-2013.JAMA,314,1905.
  31. Pucci, G,Alcidi, R,Tap, L,Battista, F,Mattace-Raso, F,Schillaci, G(2017).Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature.Pharmacol Res,120,34-42.
  32. Sims, EA(2001).Are there persons who are obese, but metabolically healthy?.Metabolism,50,1499-1504.
  33. Song, Y,Manson, JE,Meigs, JB,Ridker, PM,Buring, JE,Liu, S(2007).Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women.Am J Cardiol,100,1654-1658.
  34. St-Pierre, AC,Cantin, B,Mauriège, P(2005).Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.CMAJ,172,1301-1305.
  35. Thomsen, M,Nordestgaard, BG(2014).Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.JAMA Intern Med,174,15-22.
  36. Twig, G,Gerstein, HC,Shor, DBA(2015).Coronary artery disease risk among obese metabolically healthy young men.Eur J Endocrinol,173,305-312.
  37. Van Gaal, LF,Mertens, IL,De Block, CE(2006).Mechanisms linking obesity with cardiovascular disease.Nature,444,875-880.
  38. van Vliet-Ostaptchouk, JV,Nuotio, ML,Slagter, SN(2014).The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies.BMC Endocr Disord,14,9.
  39. Voulgari, C,Tentolouris, N,Dilaveris, P,Tousoulis, D,Katsilambros, N,Stefanadis, C(2011).Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.J Am Coll Cardiol,58,1343-1350.
  40. Westerterp, KR(2018).Changes in physical activity over the lifespan: impact on body composition and sarcopenic obesity.Obes Rev,19(Suppl 1),8-13.
  41. WHO. Cardiovascular disease. Available at: https://www.who.int/cardiovascular_diseases/about_cvd/en/. Accessed May 1, 2020
  42. Xu, Y,Li, H,Wang, A(2018).Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.Eur J Endocrinol,179,343-352.
  43. Yeh, TL,Chen, HH,Tsai, SY,Lin, CY,Liu, SJ,Chien, KL(2019).The relationship between metabolically healthy obesity and the risk of cardiovascular disease: a systematic review and meta-analysis.J Clin Med,8,1228.
  44. Zhang, R,Dong, SY,Wang, WM,Fei, SY,Xiang, H,Zeng, Q(2018).Obesity, metabolic abnormalities, and mortality in older men.J Geriatr Cardiol,15,422-427.
  45. 衛生福利部國民健康署： 2001 年國民健康調查。https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=1077&pid=6198。引用2020/08/18。Health Promotion Administration, Ministry o f Health and Welfare, R.O.C. (Taiwan). 2001 National Health Interview Survey in Taiwan (NHIS). Available at: https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=1077&pid=6198. Accessed August 18, 2020
  46. 衛生福利部國民健康署：代謝症候群。https://www.hpa.gov.tw/Pages/List.aspx?nodeid=221。引用2019/07/01。Health Promotion Administration, Ministry of Health and Welfare, R.O.C. (Taiwan). Metabolic syndrome. Available at: https://www.hpa.gov.tw/Pages/List. aspx?nodeid=221. Accessed July 1, 2019. [In Chinese]
  47. 衛生福利部國民健康署, Ministry of Health and Welfare, R.O.C. (Taiwan)。衛生福利部國民健康署：台灣地區三高調查檔主題式資料庫。https://dep.mohw.gov.tw/DOS/lp-3147-113-2-20.html。引用2020/08/18。Health Promotion Administration, Ministry of Health and Welfare, R.O.C. (Taiwan). Taiwanese Survey on Hypertension, Hyperglycemia, and Hyperlipidemia. Available at: https://dep.mohw.gov.tw/DOS/lp-3147-113-2-20.html. Accessed August 18, 2020. [In Chinese]。https://dep.mohw.gov.tw/DOS/lp-3147-113-2-20.html
  48. 542&pid 衛生福利部國民健康署社區健康組：成人健康體位標準。https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=542&pid=9737。引用2020/08/18。Health Promotion Administration, Ministry of Health and Welfare, R.O.C. (Taiwan). Adult healthy standards. Available at: https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=542&pid=9737. Accessed August 18, 2020. [In Chinese]
  49. 衛生福利部統計處：107年國人死因統計結果。https://www.mohw.gov.tw/cp-16-48057-1.html。引用2020/08/18。Department of Statistics, Ministry of Health and Welfare, R.O.C. (Taiwan). The result on the cause of death statistics in 2018. Available at: https://www.mohw.gov.tw/cp-16-48057-1.html. Accessed August 18, 2020. [In Chinese]
被引用次数
  1. 魏正,林惠玉,王政彥(2022)。臺灣規律性運動人口比率與身體質量指數變化的關係。大專體育，162，25-36。
  2. (2023)。新冠疫情下行動健康照護模式介入對健康行為及代謝症候群之影響－以台灣計程車駕駛為例。台灣公共衛生雜誌，42(6)，612-625。
  3. (2023)。一位初次腦中風病人轉銜長照復能之護理經驗。志為護理-慈濟護理雜誌，22(6)，119-128。
print cancel